Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 15

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Triglyceride uptake and lipoprotein lipase-generated fatty acid spillover in the splanchnic bed of dogs

Nelson, Robert H., Edgerton, Dale S., Basu, Rita, Roesner, Justin C., Cherrington, Alan D., Miles, John M. · 2007 · Diabetes

Abstract

The action of lipoprotein lipase on triglyceride-rich lipoproteins generates fatty acids that are either transported into tissues or mix with circulating free fatty acids (FFAs) via a process known as spillover. In the present study, arterial, portal vein, and hepatic vein sampling catheters were surgically placed in nine mongrel dogs. The animals were subsequently studied after a 42-h fast during infusion of [14C]oleate and a lipid emulsion containing [3H]triolein; the emulsion was used as a surrogate for the study of chylomicron metabolism. More than one-half of splanchnic [3H]triglyceride uptake occurred in the liver, and substantial fractional spillover of [3H]oleate was observed in both liver and nonhepatic tissues (∼50% each). There was a significant correlation between FFA release from nonhepatic tissues (presumably visceral fat) and nonhepatic fractional spillover (R = 0.81, P < 0.01), consistent with a model in which the rate of intracellular lipolysis influences spillover by determining the direction of net fatty acid flow between the cell and the interstitium. There was a significant correlation between “true” and “net” splanchnic spillover (R = 0.84, P < 0.005), the latter representing calculation of spillover between arterial and hepatic venous blood without portal venous data. Metabolism of chylomicron triglycerides in visceral fat may be an important source of portal venous FFAs.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/db06-1657

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 26

  1. Farrell JJ: Sleisenger & Fordtran's Gastrointestinal and Liver Disease. 7th ed. Feldman MD, Ed. Philadelphia, Saunders,2002
  2. Miles J, Park Y, Walewicz D, Russell-Lopez C, Windsor S, Isley W, Coppack S, Harris W: Systemic and forearm triglyceride metabolism: fate of lipoprotein lipase-generated glycerol and free fatty acids. Diabetes 53:521–527,2004 · DOI
  3. Tan GD, Fielding BA, Currie JM, Humphreys SM, Desage M, Frayn KN, Laville M, Vidal H, Karpe F: The effects of rosiglitazone on fatty acid and triglyceride metabolism in type 2 diabetes. Diabetologia 48:83–95,2005 · DOI
  4. Barrows BR, Timlin MT, Parks EJ: Spillover of dietary fatty acids and use of serum nonesterified fatty acids for the synthesis of VLDL-triacylglycerol under two different feeding regimens. Diabetes 54:2668–2673,2005 · DOI
  5. Evans K, Burdge GC, Wootton SA, Clark ML, Frayn KN: Regulation of dietary fatty acid entrapment in subcutaneous adipose tissue and skeletal muscle. Diabetes 51:2684–2690,2002 · DOI · Paper page
  6. Rebrin K, Steil GM, Getty L, Bergman RN: Free fatty acid as a link in the regulation of hepatic glucose output by peripheral insulin. Diabetes 44:1038–1045,1995 · DOI
  7. Lewis GF, Uffelman KD, Szeto LW, Weller B, Steiner G: Interaction between free fatty acids and insulin in the acute control of very low density lipoprotein production in humans. J Clin Invest 95:158–166,1995 · DOI · Paper page
  8. Stevenson RW, Steiner KE, Connolly CC, Fuchs H, Alberti KG, Williams PE, Cherrington AD: Dose-related effects of epinephrine on glucose production in conscious dogs. Am J Physiol 260:E363–E370,1991 · DOI
  9. Miles JM, Ellman MG, McClean KL, Jensen MD: Validation of a new method for determination of free fatty acid turnover. Am J Physiol 252:E431–E438,1987 · DOI · Paper page
  10. Park Y, Grellner WJ, Harris WS, Miles JM: A new method for the study of chylomicron kinetics in vivo. Am J Physiol 279:E1258–E1263,2000 · DOI
  11. Miles JM, Glasscock R, Aikens J, Gerich JE, Haymond MW: A microfluorometric method for the determination of free fatty acids in plasma. J Lipid Res 24:96–99,1983 · DOI · Paper page
  12. Jensen MD, Rogers PJ, Ellman MG, Miles JM: Choice of infusion-sampling mode for tracer studies of free fatty acid metabolism. Am J Physiol 254:E562–E565,1988 · DOI
  13. Dole VP, Meinertz H: Microdetermination of long-chain fatty acids in plasma and tissues. J Biol Chem 235:2595–2599,1960 · DOI · Paper page
  14. Mittendorfer B, Liem O, Patterson BW, Miles JM, Klein S: What does the measurement of whole-body fatty acid rate of appearance in plasma by using a fatty acid tracer really mean?Diabetes 52:1641–1648,2003 · DOI
  15. Jensen MD, Cardin S, Edgerton D, Cherrington A: Splanchnic free fatty acid kinetics. Am J Physiol 284:E1140–E1148,2003 · DOI
  16. Quarfordt SH, Hanks J, Shelburne F, Schirmer B: Differing uptake of emulsion triglyceride by the fed and fasted rat liver. J Clin Invest 69:1092–1098,1982 · DOI
  17. Bergman EN, Havel RJ, Wolfe BM, Bohmer T: Quantitative studies of the metabolism of chylomicron triglycerides and cholesterol by liver and extrahepatic tissues of sheep and dogs. J Clin Invest 50:1831–1831,1971 · DOI · Paper page
  18. Kortz WJ, Schirmer BD, Mansbach CM II, Shelburne F, Toglia MR, Quarfordt SH: Hepatic uptake of chylomicrons and triglyceride emulsions in rats fed diets of differing fat content. J Lipid Res 25:799–804,1984 · DOI
  19. Fraser R, Dobbs BR, Rogers GW: Lipoproteins and the liver sieve: the role of the fenestrated sinusoidal endothelium in lipoprotein metabolism, atherosclerosis, and cirrhosis. Hepatology 21:863–874,1995 · DOI · Paper page
  20. Redgrave TG, Maranhao RC: Metabolism of protein-free lipid emulsion models of chylomicrons in rats. Biochim Biophys Acta 835:104–112,1985 · DOI · Paper page
  21. Wolfe RR, Shaw JHF, Durkot MJ: Effects of sepsis on VLDL kinetics: responses in basal state and during glucose infusion. Am J Physiol 248:E732–E740,1985 · DOI
  22. Gormsen LC, Jensen MD, Nielsen S: Measuring VLDL-triglyceride turnover in humans using ex vivo-prepared VLDL tracer. J Lipid Res 47:99–106,2006 · DOI
  23. Coppack SW, Fisher RM, Gibbons GF, Humphreys SM, McDonough MJ, Potts JL, Frayn KN: Postprandial substrate deposition in human forearm and adipose tissues in vivo. Clin Sci 79:339–348,1990 · DOI · Paper page
  24. Nelson RH, Prasad A, Lerman A, Miles JM: Myocardial uptake of circulating triglycerides in nondiabetic patients with heart disease. Diabetes 56:527–530,2007 · DOI
  25. Bickerton AS, Roberts R, Fielding BA, Hodson L, Blaak EE, Wagenmakers AJ, Gilbert M, Karpe F, Frayn KN: Preferential uptake of dietary fatty acids in adipose tissue and muscle in the postprandial period. Diabetes 56:168–176,2007 · DOI · Paper page
  26. Miles JM, Jensen MD: Counterpoint: visceral adiposity is not causally related to insulin resistance. Diabetes Care 28:2326–2328,2005 · DOI

Cited by

See all 15

Metadata

Authors
Nelson, R. H., Edgerton, D. S., Basu, R., Roesner, J. C., Cherrington, A. D., & Miles, J. M.
Affiliations
  • Endocrine Research Unit, Mayo Clinic, Rochester, Minnesota
  • Department of Molecular Physiology and Biophysics, Vanderbilt School of Medicine, Nashville, Tennessee
Venue
Diabetes
Published
2007-07-01
Volume
56
Issue
7
Pages
1850-1855
ISSN
  • 0012-1797
  • 1939-327X
Cited by
15
References
3
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.